AURA
Price
$8.20
Change
+$0.09 (+1.11%)
Updated
Dec 20 closing price
79 days until earnings call
TSHA
Price
$1.85
Change
+$0.01 (+0.54%)
Updated
Dec 20, 04:59 PM (EDT)
93 days until earnings call
Ad is loading...

AURA vs TSHA

Header iconAURA vs TSHA Comparison
Open Charts AURA vs TSHABanner chart's image
Aura Biosciences
Price$8.20
Change+$0.09 (+1.11%)
Volume$612.49K
CapitalizationN/A
Taysha Gene Therapies
Price$1.85
Change+$0.01 (+0.54%)
Volume$12.86K
CapitalizationN/A
AURA vs TSHA Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. TSHA commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and TSHA is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (AURA: $8.20 vs. TSHA: $1.85)
Brand notoriety: AURA and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 253% vs. TSHA: 117%
Market capitalization -- AURA: $410.1M vs. TSHA: $379.15M
AURA [@Biotechnology] is valued at $410.1M. TSHA’s [@Biotechnology] market capitalization is $379.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 6 bearish.
  • TSHA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -2.50% price change this week, while TSHA (@Biotechnology) price change was -10.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

AURA is expected to report earnings on Mar 12, 2025.

TSHA is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($410M) has a higher market cap than TSHA($379M). TSHA YTD gains are higher at: 4.520 vs. AURA (-7.449). TSHA has higher annual earnings (EBITDA): -20.67M vs. AURA (-91.84M). AURA has more cash in the bank: 174M vs. TSHA (158M). AURA has less debt than TSHA: AURA (19.1M) vs TSHA (62.5M). TSHA has higher revenues than AURA: TSHA (9.92M) vs AURA (0).
AURATSHAAURA / TSHA
Capitalization410M379M108%
EBITDA-91.84M-20.67M444%
Gain YTD-7.4494.520-165%
P/E RatioN/A2.94-
Revenue09.92M-
Total Cash174M158M110%
Total Debt19.1M62.5M31%
TECHNICAL ANALYSIS
Technical Analysis
AURATSHA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KARRX9.360.10
+1.08%
Kayne Anderson Renewable Infras Retail
HMCLX14.590.13
+0.89%
Harbor Mid Cap Institutional
JEMWX30.630.19
+0.62%
JPMorgan Emerging Markets Equity R6
JDSAX22.800.11
+0.48%
Janus Henderson Small Cap Value A
AIFFX13.840.06
+0.44%
Aristotle International Equity I-2

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
N/A
LOGC - TSHA
45%
Loosely correlated
+1.51%
AURA - TSHA
35%
Loosely correlated
+1.11%
ORMP - TSHA
35%
Loosely correlated
-4.82%
ARWR - TSHA
35%
Loosely correlated
-0.26%
PRME - TSHA
35%
Loosely correlated
+3.94%
More